V1 (<14 weeks) | V2 (14–22 weeks) | V3 (23–32 weeks) | ||
---|---|---|---|---|
Controls (n = 30) | ||||
A1c [%] | 5.1 (5.0-5.2)§ | 4.7 (4.6–4.9)*§ | 5.0 (4.8–5.1)†§ | |
T1DM (n = 62) | ||||
A1c [%] | 6.3 (5.6–6.5)‡ | 5.6 (5.3–6.0)*‡ | 5.8 (5.5–6.2)*†‡ | |
TBR (< 3.5 mmol/L) [%] | 4 (1–6) | 4 (2–6) | 4 (2–6) | |
TIR (3.5–7.8 mmol/L) [%] | 70 (55–80) | 71 (63–80)* | 71 (64–81)* | |
TAR (> 7.8 mmol/L) [%] | 25 (15–41) | 23 (12–33)* | 24 (13–33)* | |
CV [%] | 31.6 (29.9–36.6) | 31.1 (28.4–34.8) | 30.3 (27.6–33.0)* |